Company Filing History:
Years Active: 2019
Title: Benjamin Hyun Joon Shin: Innovator in HPV Immunotherapy
Introduction
Benjamin Hyun Joon Shin is a notable inventor based in Houston, Texas. He has made significant contributions to the field of immunotherapy, particularly in relation to human papillomavirus (HPV) infections. His work focuses on the generation of HPV-specific T-cells, which are crucial for developing effective treatments against HPV-related diseases.
Latest Patents
Benjamin Shin holds a patent for the "Generation of HPV-specific T-cells." This patent encompasses methods and compositions aimed at immunotherapy for HPV infections and associated diseases. The specific methods involve the production of immune cells that target antigens of HPV16 and/or HPV18. Notably, his methods include stimulation steps utilizing IL-7 and IL-15, while avoiding IL-6 and/or IL-12. Additionally, certain embodiments of his patent utilize stimulations in the presence of costimulatory cells and specific antigen-presenting cells.
Career Highlights
Benjamin Shin is affiliated with the Baylor College of Medicine, where he conducts his research and development work. His innovative approaches to immunotherapy have the potential to significantly impact the treatment of HPV-related conditions. His dedication to advancing medical science is evident in his focused research efforts.
Collaborations
He collaborates with esteemed colleagues, including Carlos A. Ramos and Cliona M. Rooney. These partnerships enhance the research environment and contribute to the advancement of their shared goals in immunotherapy.
Conclusion
Benjamin Hyun Joon Shin is a pioneering inventor whose work in HPV-specific T-cell generation represents a significant advancement in immunotherapy. His contributions are poised to make a lasting impact on the treatment of HPV infections and related diseases.